What Cough Medicine Can You Take With Parkinson’s?

Most single-ingredient cough medicines are safe for people with Parkinson’s disease, but several ingredients tucked inside common over-the-counter cold and flu products can trigger serious reactions with Parkinson’s medications. The biggest risks involve dextromethorphan (the cough suppressant in brands like Robitussin DM and NyQuil) when combined with MAO-B inhibitors like selegiline or rasagiline, and decongestants like phenylephrine or pseudoephedrine paired with the same drug class. What makes the topic especially tricky is that Parkinson’s itself changes how coughing works, and many cold products bundle multiple active ingredients together, turning a single dose into a cocktail of potential interactions.

Why Parkinson’s Medications Create the Real Problem

Parkinson’s disease on its own does not make most cough medicines dangerous. The issue is the drugs used to treat it. A person taking only carbidopa-levodopa faces fewer interaction risks than someone whose regimen also includes an MAO-B inhibitor (selegiline, rasagiline, or safinamide), a COMT inhibitor (entacapone or opicapone), or amantadine. Each of these adds its own set of ingredients to watch out for. Because Parkinson’s treatment often involves multiple drugs at once, the interaction landscape gets complicated fast.

The most dangerous interactions fall into two categories: those that can spike blood pressure to crisis levels and those that can flood the brain with too much serotonin. Both can be triggered by ingredients that seem harmless in a person not taking Parkinson’s drugs.

Dextromethorphan and the Serotonin Syndrome Risk

Dextromethorphan, often labeled “DM” on cough syrup bottles, is the single most widely used cough suppressant in over-the-counter products. For most people it is perfectly safe at recommended doses. But it works partly by inhibiting serotonin reuptake, and that mechanism becomes dangerous when combined with MAO-B inhibitors. MAO inhibitors slow the breakdown of serotonin in the brain. Adding a drug that also increases serotonin can push levels high enough to cause serotonin syndrome, a condition marked by agitation, rapid heart rate, high blood pressure, muscle rigidity, and in severe cases, seizures or death.

A review of clinically relevant drug interactions with monoamine oxidase inhibitors found that patients on any MAOI should avoid medications that increase serotonin levels through reuptake inhibition, listing dextromethorphan specifically alongside chlorpheniramine and brompheniramine as drugs to steer clear of.¹ This is not a theoretical risk. A published case report described a 63-year-old man on levodopa, entacapone, and selegiline who developed serotonin syndrome after taking a compound cold medicine (CONTAC NT, which contains dextromethorphan among other ingredients).²

If you take selegiline, rasagiline, or safinamide, dextromethorphan is off limits. Full stop. That rules out a large chunk of the cough medicine aisle, because DM appears in dozens of brand-name products. Always check the active ingredients panel, not just the brand name, since formulations change and the same brand may sell DM and non-DM versions side by side.

Decongestants and Blood Pressure Spikes

Phenylephrine, pseudoephedrine, and oxymetazoline are sympathomimetic agents, meaning they activate the same pathways as adrenaline. Normally this just shrinks swollen nasal passages. But MAO inhibitors prevent the normal breakdown of norepinephrine and other catecholamines, so when a sympathomimetic adds more stimulation on top, blood pressure can rise sharply and unpredictably. The concern is hypertensive crisis, a sudden spike that can cause stroke, heart attack, or organ damage.

Research on selegiline’s interaction with sympathomimetic agents confirmed that medications inhibiting monoamine oxidase type A can amplify the blood-pressure-raising effects of these amines.³ The same interaction review that flagged dextromethorphan also lists phenylephrine and oxymetazoline as drugs to avoid with MAOIs due to their sympathomimetic actions.¹

These decongestants show up not only in oral cold tablets but also in some nasal sprays (oxymetazoline is the active ingredient in Afrin-type sprays). Even topical nasal application can deliver enough drug to matter when the enzyme that would normally break it down is blocked. If you are on an MAO-B inhibitor, saline nasal spray is a safer way to ease congestion.

Acetaminophen and Amantadine

Acetaminophen (Tylenol and its equivalents) is generally one of the safest pain and fever relievers for people with Parkinson’s. It does not interact with levodopa, dopamine agonists, or MAO-B inhibitors in any clinically meaningful way. However, for the subset of patients taking amantadine, the picture is murkier.

A case report documented acute psychosis triggered by the combination of amantadine and acetaminophen, leading the authors to warn clinicians to be alert to this potential interaction.⁴ A separate report described psychosis in a healthy man who took Chinese cold-and-flu tablets containing amantadine, reinforcing the idea that amantadine’s psychoactive potential can be unmasked in the context of other medications.⁵

This does not mean every person on amantadine will have a problem with acetaminophen. Case reports represent individual events, not population-level risk. But if you take amantadine and notice confusion, hallucinations, or unusual agitation after using acetaminophen-containing products, it is worth bringing up with your neurologist. And be aware that some cold-and-flu products sold internationally actually contain amantadine itself as an antiviral ingredient, which could effectively double the dose without you realizing it.

Antihistamines and Anticholinergic Load

First-generation antihistamines like diphenhydramine (Benadryl) and chlorpheniramine are common in nighttime cold formulas and allergy-plus-cough products. They suppress cough partly through their drying effect on mucous membranes and partly through mild sedation. For people with Parkinson’s, they carry two concerns.

First, chlorpheniramine and brompheniramine have serotonin-reuptake-inhibiting properties, placing them in the same danger zone as dextromethorphan when combined with MAO-B inhibitors.¹ Second, all first-generation antihistamines have strong anticholinergic effects, which can worsen cognitive fog, constipation, urinary retention, and dry mouth, all of which are already common in Parkinson’s. The anticholinergic load from even a single dose of diphenhydramine can be significant in someone whose brain is already depleted of dopamine and acetylcholine balance is already off.

Second-generation antihistamines like cetirizine (Zyrtec) and loratadine (Claritin) cross into the brain much less and carry far less anticholinergic burden. They are primarily for allergies rather than cough, but if your cough is driven by postnasal drip, they can help without the same risk profile. Interestingly, a computational study predicted that certain antihistamines, including levocetirizine, could theoretically serve as adjuvant therapies for Parkinson’s by counteracting oxidative stress and rebalancing neurotransmitters, though this remains a prediction from text mining rather than clinical evidence.⁶

What Is Generally Considered Safer

With so many ingredients to avoid, the natural question is what you actually can take. For most people with Parkinson’s, the following single-ingredient options carry fewer interaction risks:

Guaifenesin: This expectorant (the active ingredient in plain Mucinex) thins mucus so you can cough it up more effectively. It has no known interactions with levodopa, dopamine agonists, MAO-B inhibitors, or COMT inhibitors. It does not suppress the cough reflex, which is actually a benefit in Parkinson’s since cough suppression can increase aspiration risk.
Honey: Clinical trials in other populations have shown honey to be as effective as dextromethorphan for nighttime cough in some contexts. It carries zero drug interaction risk, costs almost nothing, and can soothe throat irritation. A teaspoon in warm water or tea before bed is a reasonable first-line approach.
Saline nasal spray or rinse: If your cough is driven by postnasal drip, saline irrigation addresses the source without any systemic medication.
Acetaminophen: For fever or sore throat pain, acetaminophen is generally safe with most Parkinson’s medications. Exercise extra caution if you take amantadine, as noted above.

The key principle is to use the fewest active ingredients possible and to read the label of anything you buy. A product marketed simply as “cough syrup” may contain four or five active ingredients including a decongestant and an antihistamine alongside the cough suppressant.

The Combination Product Trap

Multi-symptom cold and flu products are where the real danger hides. A single caplet of a nighttime cold formula might contain acetaminophen, dextromethorphan, doxylamine (an antihistamine), and phenylephrine. For someone taking selegiline, that is three potential interactions in one pill: serotonin syndrome risk from the DM, serotonin risk from the antihistamine, and hypertensive risk from the decongestant.

The case of the 63-year-old man who developed serotonin syndrome illustrates this perfectly. He had been stable on his Parkinson’s medications for years. It was the addition of a compound cold medicine, not any single ingredient in isolation, that tipped him into crisis.² Compound formulations make it easy to accidentally take something dangerous because consumers tend to think of the product by its brand name (“I just took some NyQuil”) rather than mentally parsing each active ingredient against their medication list.

A French research team recognized how confusing this landscape is and developed a practical guide summarizing drug-drug interactions between over-the-counter medications and anti-Parkinson drugs. When they tested the guide with patients and community pharmacists, both groups found it relevant and useful, suggesting that even professionals benefit from a structured reference for these interactions.⁷ Until similar tools become widespread, the safest habit is to hand your pharmacist a list of your Parkinson’s medications before buying any cold or cough product and ask them to check for conflicts.

Why Cough Works Differently in Parkinson’s

Beyond drug interactions, there is a deeper reason to think carefully about cough medicine when you have Parkinson’s. The disease itself weakens the cough reflex, sometimes dramatically. Aspiration pneumonia, which happens when food, liquid, or saliva enters the lungs without being coughed back out, is a leading cause of death in people with Parkinson’s.⁸

The problem is twofold. First, the muscles involved in generating a forceful cough become weaker as the disease progresses. Second, the sensory side of the reflex dulls: the brain becomes less sensitive to material entering the airway, so the urge to cough comes later or not at all. Research has shown that cough reflex sensitivity can help predict how severely a person with Parkinson’s will aspirate, and that the subjective urge-to-cough threshold is a meaningful marker for distinguishing people who merely have material touch their vocal folds from those who actually aspirate it into their lungs.⁹

This means that suppressing a cough in Parkinson’s can be actively harmful. A healthy person with a cold might benefit from quieting a dry, irritating cough so they can sleep. A person with Parkinson’s might need every cough they can muster to keep their airway clear. Before reaching for any cough suppressant, it is worth asking whether the cough is genuinely nonproductive and disruptive, or whether it is doing important protective work.

Strengthening the Cough Without Medicine

Given the risks of cough suppressants and the importance of maintaining cough strength, non-drug approaches deserve attention. Expiratory muscle strength training, which involves breathing forcefully against a calibrated resistance device, has been studied specifically in people with Parkinson’s. A randomized controlled trial found that both a targeted cough skill training program and expiratory muscle strength training improved voluntary cough force, with the improvements reaching statistical significance.¹⁰ An earlier study found that four weeks of expiratory muscle strength training increased cough effectiveness in Parkinson’s patients, as measured by the airflow volume acceleration, which reflects how well a cough can create the shearing forces that dislodge material from the airway.¹¹

A more recent study added variable practice during cough skill training, an approach borrowed from motor learning research, and found that peak expiratory flow rate improved for both single and sequential coughs and that gains held one month after training stopped.¹² These exercises do not replace medical treatment for a chest infection, but they can build the baseline cough strength that helps prevent aspiration between illnesses. A speech-language pathologist with experience in Parkinson’s can typically prescribe and supervise a program.

Managing Excess Saliva and Postnasal Drip

Some coughs in Parkinson’s are not from colds at all but from the disease’s effects on swallowing and saliva management. Drooling (sialorrhea) is common, and pooled saliva at the back of the throat can trigger coughing or, worse, silently slip into the airway. This kind of cough does not respond to typical cough medicines because the underlying problem is swallowing dysfunction, not airway inflammation.

For drooling-related cough, anticholinergic treatments that target saliva production can be more logical than a cough syrup. Ipratropium bromide spray applied under the tongue has been studied as a locally acting option. Because ipratropium does not cross the blood-brain barrier, it avoids the cognitive side effects of systemic anticholinergics like glycopyrrolate or atropine drops.¹³ Botulinum toxin injections into the salivary glands are another option for severe cases, though these require a specialist and repeat visits.

If your cough seems worst when lying down, or you notice it is accompanied by a wet or gurgly voice quality, the cough is likely related to swallowing rather than respiratory infection. Bringing this up with your neurologist or a speech-language pathologist can lead to more targeted treatment than any over-the-counter product would provide.

A Quick-Reference Approach for the Medicine Aisle

Navigating the cough medicine aisle with Parkinson’s does not need to be overwhelming if you follow a few habits. Keep an updated list of your medications in your phone or wallet, including the drug class (your pharmacist can help label which are MAO-B inhibitors, COMT inhibitors, and so on). When picking up a cold product, flip it over and read every active ingredient, not just the one featured on the front of the box. Cross-check any ingredient you do not recognize with your pharmacist before buying it.

Products with the fewest active ingredients are almost always the better choice. A plain guaifenesin product for chest congestion, a simple saline rinse for nasal stuffiness, and acetaminophen for fever or pain will address most cold symptoms without venturing into dangerous territory. If your cough is dry and persistent enough to genuinely need suppression, and you are on an MAO-B inhibitor, ask your doctor about prescription alternatives to dextromethorphan such as benzonatate (Tessalon Perles), which works by numbing stretch receptors in the lungs and has no known serotonin activity. Reserve that conversation for coughs that are truly disruptive, keeping in mind that in Parkinson’s, the cough reflex is doing more protective work than you might think.